Community education and navigation to improve breast cancer screening uptake in Malaysia

Improving early detection of breast cancer in Malaysia during the COVID-19 pandemic - the use of mHealth to improve community education and navigation: a study protocol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15196866

Enrollment

932

Registered

2022-08-10

Start date

2021-09-02

Completion date

Unknown

Last updated

2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Breast Examination (CBE) screening for breast cancer early detection Cancer

Interventions

This study was a randomised controlled trial and participants were randomised to either an intervention group (IG) or a control group (CG). Participant enrolment was conducted by trained data collecto

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Residents from Sungai Segamat and Jabi (Malaysia) who were recorded in the South East Asia Community Observatory (SEACO) database, completed the 2018 SEACO health survey and have previously given consent to be contacted about participating in other research studies. 2. Women aged 40 - 74 years 3. Registered a phone number with SEACO. Only women who were able to provide a mobile phone number when contacted were able to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Breast cancer patients and survivors. 2. Women who reported to the researchers at the time of the interview that they are experiencing breast cancer symptoms were excluded from the research and encouraged to seek help from their local doctor as soon as possible.

Design outcomes

Primary

Measure	Time frame
Clinical breast examination (CBE) screening uptake measured using records from the LPPKN clinic at follow-up as well as self-reported data at baseline and follow-up.	—

Secondary

Measure	Time frame
1. Breast cancer symptom recognition measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 2. Intention to attend a CBE measured using the question ‘I intend to have a Clinical Breast Examination to check for breast cancer in the near future’ and a 5-point Likert scale for participants to rate their response at baseline and follow-up. 3. Beliefs and barriers regarding breast cancer and breast cancer screening measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 4. Practice of breast self-examination measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 5. Mammogram screening attendance (for CBE-positive women) measured using LPPKN clinic records at follow-up.	—

Measure

Time frame

1. Breast cancer symptom recognition measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 2. Intention to attend a CBE measured using the question ‘I intend to have a Clinical Breast Examination to check for breast cancer in the near future’ and a 5-point Likert scale for participants to rate their response at baseline and follow-up. 3. Beliefs and barriers regarding breast cancer and breast cancer screening measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 4. Practice of breast self-examination measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up. 5. Mammogram screening attendance (for CBE-positive women) measured using LPPKN clinic records at follow-up.

—

Countries

Malaysia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026